EE528 Comparative Effectiveness Modeling of an Anti-Pd-1 Antibody Drug Intervention for Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in the U.S.
Abstract
Authors
N Ventura
N Ventura
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now